Arteris (AIP) Scheduled to Post Quarterly Earnings on Tuesday

Arteris (NASDAQ:AIPGet Free Report) will be releasing its earnings data after the market closes on Tuesday, November 5th. Analysts expect Arteris to post earnings of ($0.14) per share for the quarter. Arteris has set its FY 2024 guidance at EPS and its Q3 2024 guidance at EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.

Arteris (NASDAQ:AIPGet Free Report) last issued its earnings results on Thursday, August 1st. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.07). Arteris had a negative net margin of 68.37% and a negative return on equity of 274.66%. The business had revenue of $14.58 million for the quarter, compared to the consensus estimate of $13.68 million. During the same quarter in the previous year, the firm posted ($0.25) EPS. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Arteris Stock Up 3.9 %

NASDAQ:AIP opened at $7.11 on Tuesday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.17. Arteris has a 12-month low of $4.20 and a 12-month high of $9.54. The stock’s fifty day simple moving average is $7.48 and its 200-day simple moving average is $7.63. The firm has a market capitalization of $273.59 million, a P/E ratio of -6.90 and a beta of 1.11.

Analyst Ratings Changes

AIP has been the topic of a number of recent analyst reports. Westpark Capital restated a “buy” rating and set a $11.00 target price on shares of Arteris in a report on Wednesday, July 31st. Rosenblatt Securities restated a “buy” rating and set a $15.00 price objective on shares of Arteris in a report on Monday, August 5th.

Read Our Latest Research Report on AIP

Insider Activity at Arteris

In other Arteris news, CFO Nicholas B. Hawkins sold 4,958 shares of the business’s stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $7.13, for a total transaction of $35,350.54. Following the transaction, the chief financial officer now owns 211,713 shares of the company’s stock, valued at $1,509,513.69. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, Director Wayne C. Cantwell sold 15,000 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $6.95, for a total transaction of $104,250.00. Following the transaction, the director now owns 243,198 shares in the company, valued at approximately $1,690,226.10. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Nicholas B. Hawkins sold 4,958 shares of the company’s stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $7.13, for a total transaction of $35,350.54. Following the completion of the transaction, the chief financial officer now owns 211,713 shares in the company, valued at $1,509,513.69. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 135,360 shares of company stock valued at $988,781. 33.70% of the stock is owned by insiders.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

See Also

Earnings History for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.